— Know what they know.
Not Investment Advice

ACLX Earnings

Arcellx, Inc.
1W: +0.0% 1M: +0.2% 3M: +68.6% YTD: +81.7% 1Y: +77.8% 3Y: +180.7%
$115.07
Last traded 2026-05-15 — delisted
NASDAQ · Healthcare · Biotechnology · $6.7B mcap · 43M float · 3.37% daily turnover · Short 30% of daily vol
Last Earnings 2026-02-26
EPS
$-1.01
▲ Beat +0.0%
Revenue
$4M
▼ Miss -65.0%
Next Earnings 2026-05-07
EPS Estimate
$-1.02
Range: $-1.44 - $-0.85
Revenue Estimate
$31M
3 analysts

Estimate vs Actual

Earnings Surprise History

9/19
EPS Beats
3/19
Revenue Beats
47%
EPS Beat Rate
16%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-04-20 annual 2026-12-31 $-3.67 $-3.67 — $73,344,315 $73,344,315
2026-04-07 annual 2030-12-31 $— $7.42 ▲ 7.42 $— $1,080,611,750
2026-04-07 quarter 2026-03-31 $-1.12 $-1.11 ▲ 0.01 $6,309,450 $6,072,692
2026-04-07 annual 2026-12-31 $-3.71 $-3.67 ▲ 0.04 $73,661,615 $73,344,315
2026-04-07 annual 2028-12-31 $0.41 $0.39 ▼ 0.02 $467,399,567 $446,160,034
2026-04-07 quarter 2025-12-31 $-1.06 $-1.04 ▲ 0.02 $8,413,385 $12,561,438
2026-04-07 annual 2025-12-31 $-4.09 $-4.05 ▲ 0.04 $28,761,063 $32,963,881
2026-04-07 annual 2027-12-31 $-1.71 $-1.71 — $261,943,607 $261,669,021
2026-04-01 quarter 2026-03-31 $-1.11 $-1.12 ▼ 0.01 $6,608,400 $6,309,450
2026-04-01 quarter 2026-09-30 $-1.02 $-1.07 ▼ 0.05 $21,014,133 $17,990,900
2026-04-01 annual 2029-12-31 $4.01 $3.87 ▼ 0.14 $755,822,444 $742,687,750
2026-04-01 quarter 2026-12-31 $-0.97 $-1.01 ▼ 0.04 $31,107,056 $28,595,437
2026-04-01 annual 2028-12-31 $0.65 $0.41 ▼ 0.24 $482,817,788 $467,399,567
2026-04-01 quarter 2026-06-30 $-1.17 $-1.18 ▼ 0.01 $6,654,756 $6,449,100
2026-04-01 annual 2025-12-31 $-4.08 $-4.09 ▼ 0.01 $29,163,353 $28,761,063
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms